In order to understand the participation of BCL-xL in leukemia, we carried out a bioinformatic analysis with the help of the ONCOMINE database, using the public data reported by Anderson and Co. [44], which allowed to evaluate the expression of this protein in AML, B-ALL and T-ALL. Here, BCL2L1 is linked to leukemia.